Last $14.18 USD
Change Today -1.04 / -6.83%
Volume 67.4K
CALA On Other Exchanges
Symbol
Exchange
NASDAQ GS
Berlin
OTC US
As of 2:39 PM 03/2/15 All times are local (Market data is delayed by at least 15 minutes).

calithera biosciences inc (CALA) Snapshot

Open
$15.25
Previous Close
$15.22
Day High
$15.25
Day Low
$13.76
52 Week High
12/15/14 - $33.48
52 Week Low
10/10/14 - $6.51
Market Cap
254.3M
Average Volume 10 Days
30.1K
EPS TTM
--
Shares Outstanding
17.9M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CALITHERA BIOSCIENCES INC (CALA)

Related News

No related news articles were found.

calithera biosciences inc (CALA) Related Businessweek News

No Related Businessweek News Found

calithera biosciences inc (CALA) Details

Calithera Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer. Its lead product candidate includes CB-839, an inhibitor of glutaminase, which is in three Phase I clinical trials for the treatment of patients with solid tumors, leukemias, lymphomas, and multiple myeloma. The company was founded in 2010 and is headquartered in South San Francisco, California.

39 Employees
Last Reported Date: 11/14/14
Founded in 2010

calithera biosciences inc (CALA) Top Compensated Officers

Co-Founder, Chief Executive Officer, Presiden...
Total Annual Compensation: $484.8K
Senior Vice President of Research
Total Annual Compensation: $364.1K
Senior Vice President of Drug Discovery
Total Annual Compensation: $364.1K
Compensation as of Fiscal Year 2013.

calithera biosciences inc (CALA) Key Developments

Calithera Biosciences, Inc. Presents at 17th Annual BIO CEO & Investor Conference, Feb-09-2015 05:00 PM

Calithera Biosciences, Inc. Presents at 17th Annual BIO CEO & Investor Conference, Feb-09-2015 05:00 PM. Venue: The Waldorf Astoria, New York, New York, United States. Speakers: Susan M. Molineaux, Co-Founder, Chief Executive Officer, President and Director.

Calithera Biosciences, Inc. Presents at Leerink's Global Healthcare Conference, Feb-11-2015 03:55 PM

Calithera Biosciences, Inc. Presents at Leerink's Global Healthcare Conference, Feb-11-2015 03:55 PM. Venue: Waldorf Astoria New York, New York, New York, United States. Speakers: Susan M. Molineaux, Co-Founder, Chief Executive Officer, President and Director.

Calithera Biosciences Appoints Keith Orford to Vice President of Clinical Development

Calithera Biosciences, Inc. announced the appointment of Dr. Keith Orford, M.D. Ph.D., as Vice President of Clinical Development. He joins the company following a distinguished career in oncology pharmaceuticals development, including senior clinical roles with GlaxoSmithKline (GSK) and Merck. At Calithera, Dr. Orford will be responsible for clinical development of CB-839, its lead oral product candidate in tumor metabolism, as well as subsequent clinical development programs. Dr. Orford joins Calithera from GSK where he was the Clinical Development Lead in the Immuno-Oncology and Combinations Development Performance Unit, overseeing the clinical activities on multiple early stage clinical trials with targeted agents and novel immune-based therapies. Prior to GSK, Dr. Orford was at Merck, where he worked on early clinical development programs across oncology and other therapeutic areas. He completed his clinical training in Internal Medicine and postdoctoral work at Massachusetts General Hospital (MGH) and Harvard Medical School (HMS), studying the epigenetic regulation of hematopoietic and embryonic stem cell differentiation, becoming a Research Fellow and then an Instructor at MGH/HMS.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CALA:US $14.18 USD -1.04

CALA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CALA.
View Industry Companies
 

Industry Analysis

CALA

Industry Average

Valuation CALA Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CALITHERA BIOSCIENCES INC, please visit www.calithera.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.